Core Viewpoint - Numerous brokerage firms are facilitating investor participation in the Sci-Tech Innovation Board's growth tier, with several firms like CITIC Securities and Guosen Securities enabling trading permissions through their apps, indicating a step closer for investors to engage in upcoming IPOs and trading of companies listed in this tier [1][4]. Group 1: Trading Permissions and Requirements - Investors must meet the same criteria as for the Sci-Tech Innovation Board, requiring personal assets of over 500,000 yuan and at least two years of investment experience to participate in the growth tier [1]. - Several brokerage firms have issued announcements regarding the signing of the "Risk Disclosure Statement for the Sci-Tech Innovation Board Growth Tier," ensuring investors can easily sign through online channels [1][4]. Group 2: Risk Disclosure and Management - The importance of risk disclosure is emphasized, requiring investors to understand the specific risks associated with growth tier companies, including their unprofitability and uncertainties in technology development and market prospects [4][6]. - The Shanghai Stock Exchange has revised rules to help investors better understand the investment risks of unprofitable companies, adding essential clauses to the risk disclosure statement [4]. Group 3: Market Opportunities and Challenges - The listing of growth tier companies introduces new investment opportunities but also demands higher risk identification and management capabilities from investors due to the inherent uncertainties in revenue and profitability [6]. - Currently, two companies, Heyuan Biotechnology and Beixin Life, have successfully passed the review and are awaiting listing in the growth tier, with more unprofitable companies in the IPO queue, indicating a diversification of investment options in the future [6].